The FDA today removed N95 respirators from its medical device shortage list.
The agency credited increased domestic manufacturing of the face masks, new supply chain data from the industry and federal government, and approval from the Centers for Disease Control and Prevention’s National Institute for Occupational Safety and Health (NIOSH) of new disposable N95s and reusable respirators.
The FDA did not announce any new additions to the device shortage list, but added two brands of needles and syringes (product code GAA) and two brands of viral transport media (product codes QMC and JSM) to its device discontinuance list.
The FDA last month identified new shortages of automated external defibrillators (AEDs), chest drains/suction canisters and autotransfusion systems.
Respirators were one of the first medical devices identified in c…